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ABSTRACT 
 
Background:  Historically, surgical replacement of the aortic root in Marfan syndrome 
patients involved replacing the native valve with a mechanical valve resulting in the 
need for life-long anticoagulation. Recently, surgeons have developed procedures that 
spare, rather than replace the aortic valve during aortic root replacement. The goal of 
this systematic review is to compare valve-sparing aortic root replacement with 
traditional aortic root replacement with mechanical valves, and evaluate the evidence 
using the GRADE system.  
 
Methods: An extensive review of the literature was conducted using Medline-Ovid, 
PubMed, and Cinhal. Three articles that met the inclusion criteria were included in the 
review.  
 
Results:  Similar intraoperative and early mortality rates were demonstrated between 
aortic root replacement with AVR and AVS. Two studies showed increased late 
morbidity of thromboembolic events associated with AVR compared to AVS. Follow-up 
times between the two groups in each study differed drastically, making it difficult to 
draw final conclusions regarding long-term outcomes.  
 
Conclusions:  Although aortic root replacement with either AVR or AVS provides a low 
risk of early mortality, there are insufficient long-term data on late mortality that support 
recommending valve-sparing (AVS) procedures over valve-replacing (AVR) procedures 
at this time. After applying the GRADE system to the review, the overall quality of the 
evidence was determined to be low.  
 
Keywords:  Marfan syndrome, valve-sparing, heart valve prosthesis  
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Background 
 Prior to advances in medical technology and surgical techniques in the mid-20th 
century, men and women with the inherited connective tissue disorder first described in 
1896 as Marfan syndrome (MFS) were at high risk of premature mortality secondary to 
cardiovascular complications such as aortic aneurysm, aortic regurgitation, and aortic 
dissection (De Paepe, Devereux, Dietz, Hennekam and Pyeritz, 1996). In general, life 
expectancy for these patients was between twenty and thirty years (Murdoch, Walker, 
Halpern, Kuzma, and McKusick, 1972).  However, as cardiothoracic surgery around the 
globe became more advanced and surgeons began experimenting with methods that 
focused on replacing aortic roots in MFS patients with composite grafts and 
mechanical valves, life expectancies improved (Cameron et al., 2009).  
 In 1968, the Bentall procedure was published in the literature (Bentall and 
DeBono, 1968). First performed by Dr. Hugh Bentall and Anthony De Bono at London 
Hammersmith Hospital, the surgery involved replacing the proximal portion of the 
ascending aorta with a Teflon graft, and substituting a durable, mechanical Starr aortic 
valve in place of the patient’s native aortic valve (Bentall and DeBono, 1968). This 
procedure, hereafter referred to as AVR, provided a number of advantages for patients 
with Marfan syndrome. For instance, patients whose aortic roots were already 
dangerously dilated, or who had pre-existing aortic aneurysms or dissections could 
now be surgically treated with favorable long-term survival rates (Cameron et al., 
2009). However, having an implanted mechanical valve meant mandatory long-term 
anticoagulation to prevent fatal thromboembolic events. As such, the use of 
anticoagulants such as warfarin sodium in MFS patients carries a risk of life-
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threatening complications from bleeding (Horstkotte, Shulte, Biercks, and Strauter, 
1993). Although the Bentall procedure has been the “gold standard” for aortic root 
replacement since the late 1960s, newer procedures have emerged that rely on 
methods of salvaging and repairing native aortic valves in patients who need surgical 
intervention on their aortic roots (Gott et al., 1999).   
 Birks et al. (1998) found that aortic valve-sparing root replacement (AVS) 
emerged in the later half of the 20th century as a way to repair aortic aneurysms and 
dilated aortic roots in patients with MFS without having to utilize mechanical or 
bioprosthetic valves. Surgeons began to experiment with methods of preserving the 
native aortic valves in MFS patients hoping this would provide an effective alternative—
especially for children, young adults, and women desiring to become pregnant—to 
traditional non-valve sparing techniques that required lifelong anticoagulation. David 
and Feindel (1992) showed that early results were promising. As more young patients 
with MFS began to undergo prophylactic aortic root replacement to prevent future 
complications from aortic aneurysm and dissection, AVS procedures began to gain 
ground among cardiothoracic surgery programs. Although the Bentall procedure is still 
the preferred method for definitive root replacement in MFS patients due to its 
durability and reproducible results, AVS root replacement appears to be a good 
alternative for non-emergent aortic root replacement when the patient’s aortic valve is 
salvageable (Cameron et al., 2009). Still, because it is a “newer” procedure and has 
not been widely adopted as a standard method for aortic root replacement, the data 
are somewhat limited when compared to traditional AVR.  
Purpose of the Study 
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The purpose of this study is to review the literature on aortic root replacement with 
AVR versus AVS in Marfan syndrome patients, and to explore differences in early and 
late morbidity and mortality. Ultimately, by utilizing a standardized GRADE (Grading of 
Recommendations Assessment, Development and Education) system, the studies 
included in this review will be critically appraised and “graded” according to this system.  
This GRADE system is an internationally recognized method whose purpose is to rank 
the quality of evidence according to certain characteristics and variables. For instance, 
randomized clinical control trials are considered to be of the highest quality evidence. 
Still, the quality of evidence found in randomized trials can be lowered due to study 
limitations, inconsistency of results, indirect evidence, imprecise results, and bias. On 
the other hand, cohort and case-control studies are considered to be low quality 
evidence. However, a low quality study may be graded upwards if the treatment effect 
is large, or if there is evidence of a dose-response relationship. In this review, after 
reviewing the results, the treatment effect, and any study limitations, a final ranking will 
be given to the evidence as a whole, and will result in a high, moderate, low, or very 
low grade.  
METHOD 
 
 A systematic review of the literature was conducted using the following search 
vehicles: Medline-Ovid, PubMed, and Cinhal. Studies were sought comparing 
outcomes between aortic root replacement with valve-sparing procedures (AVS) and 
aortic root replacement with mechanical valve replacement (AVR). These databases 
were accessed through the Pacific University Library system. The search was limited to 
studies published since 2001, written in the English language, involving human 
 8 
subjects, and included in Core Clinical Journals. Several defined key words or phrases 
including “Marfan Syndrome,” “valve-sparing,” and “heart valve prosthesis” yielded a 
total of 19 articles. After applying the inclusion and exclusion criteria listed below, three 
articles were included for review.  
Inclusion Criteria 
 Articles that directly addressed outcomes between aortic valve-sparing 
procedures and composite grafting with mechanical valve replacement were included. 
Articles whose study populations consisted of pediatric and adult patients were 
included. Since valve-sparing procedures are a relatively recent phenomenon with the 
newest AVS techniques becoming more globally disseminated within the last ten years, 
only studies published after 2001 were included.  
Exclusion Criteria 
 Duplicate articles, as well as editorial articles, case studies, and meta-analyses 
were not included for purposes of this systematic review. A large number of studies 
whose abstracts were reviewed compared outcomes between different types of valve-
sparing procedures. As these studies did not specifically address the clinical question, 
they were excluded.  Studies whose primary participants did not have the Marfan 
syndrome were also not included.  
Two relevant studies (Gott et al., 2002 and Patel et al., 2008) discovered during 
the literature search were versions of a final study published in 2009 (Cameron 
et al., 2009). For purposes of clarity, and so as to not re-synthesize similar data 
three separate times, both earlier versions were excluded.  
RESULTS  
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Three studies were chosen for review. They consisted of two retrospective 
cohort studies and one prospective cohort study. There were no randomized control 
trials that met the inclusion and exclusion criteria. In brief, a total of 642 patients 
enrolled in these three studies and previously diagnosed with Marfan syndrome 
underwent aortic root replacement between September 1976 and January 2008. Three 
hundred eighty-nine patients received AVR with a composite graft and mechanical 
valve, 235 received AVS, 16 had AVR with homografts, and 2 patients received AVR 
with porcine xenografts. The two retrospective studies were performed at the world-
renowned medical institutions Johns Hopkins Medical Center in Baltimore, Maryland 
and Hannover Medical School in Hannover, Germany. The prospective cohort study 
was implemented by a consortium of researchers who designed an international 
registry study from 18 sites in Europe and North and South America.  
Aortic Root Replacement in 372 Marfan Patients:  
Evolution of Operative Repair Over 30 Years 
 
 In this retrospective cohort study by Cameron et al. (2009) spanning three 
decades, 372 Marfan syndrome patients who underwent aortic root replacement with 
AVR versus AVS were analyzed for outcomes including early and late morbidity and 
mortality, as well as freedom from thromboembolism, and reoperation rates. Two 
hundred sixty-nine patients received composite graft repair (AVR, aka Bentall 
procedure), 85 patients underwent aortic root replacement with AVS, 16 received a 
homograft, and two had porcine xenografts. Participants underwent surgical 
procedures and subsequent follow-up between September 1976 and September 2006. 
All patients were pooled from a single collegiate institution: Johns Hopkins Medical 
Center. Data regarding study participants was generated from clinical records, and 
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follow-up was conducted by directly contacting the patients and their primary care 
providers.  
Patient characteristics 
 Of the patients 265 patients were male (71%), and 107 were female (29%).  
Patient age was separated into four groups. Twenty pediatric patients (< 18yr) had 
AVR, and 19 had AVS. Sixty-six (66) patients between the ages of 18-27 had AVR, 
and 18 had AVS. Eighty-nine (89) patients between the ages of 28-37 had AVR, and 
21 received AVS. Ninety-four (94) patients older than 38 (> 38yr) had AVR, and 27 had 
AVS. Mean age was 32.9 years, with an extremely wide range (1.5 to 73 years). In the 
AVR group, a total of 59 patients had aortic dissections at the time of operation; 27 of 
those were classified as acute (< 14 days old), and 34 were chronic (> 14 days old). 
There were no aortic dissections noted in the AVS group. A total of 327 patients 
underwent elective surgery, whereas 45 patients underwent urgent or emergent 
surgery.  
Operative technique 
 Between 1976 and 2000, 85% of all patients who underwent surgery had AVR 
consisting of a Bentall composite graft with mechanical valve replacement. Between 
1998 and 2006, a total of 61% of all patients undergoing surgery had AVS. All 85 
patients who underwent AVS received one of two variations in valve-sparing 
procedures. Forty patients received a David II remodeling procedure, and one patient 
received a David I reimplantation. A total of 44 patients received a David reimplantation 
technique with Valsalva graft. From May 2002 until the conclusion of the study, this 
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modified reimplantation method with aforementioned Valsalva graft was the preferred 
technique utilized by surgeons.  
Intraoperative & early results 
 Of the patients who underwent elective surgery in either group (n=327), there 
were no operative deaths, and there were no mortalities noted within 30 days of 
surgery. Of the 45 patients who underwent emergent surgery, two deaths occurred 
within 30 days of the operation. The two intraoperative deaths resulted from a ruptured 
aorta with subsequent pericardial tamponade. Within the group of 45 patients who 
underwent emergent surgery, 35 patients had either acute or chronic aortic dissection, 
and 10 patients had imminent aortic rupture, or impaired cardiac output resulting from a 
dysfunctional left ventricle.  
Late results  
 Of the 370 patients who survived beyond thirty days post-operatively, 74 deaths 
had occurred at the time of the study’s conclusion. Ten patients died from 
complications due to dissection or rupture of the residual aorta. Nine patients died from 
complications of heart arrhythmia, and three patients died of prosthetic heart-valve 
endocarditis. In 26 cases, cause of death was unknown. The remaining deaths were 
attributed to a wide variety of etiologies including congestive heart failure, intracerebral 
hemorrhage, sepsis, multi-organ failure, cancer, drug overdose, motor vehicle 
accident, peritonitis, and respiratory failure. Of the 74 deaths, 70 patients had received 
AVR with a Bentall composite graft, 2 patients had AVS, and 2 had a homograft. Of the 
2 mortalities in the AVS cohort, one died secondary to complications of a 
thoracoabdominal aortic aneurysm repair 9 years after receiving AVS, and one died 10 
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years after AVS from biventricular failure while awaiting heart transplantation. Of the 44 
patients with AVS who received the newer Valsalva graft, there were no late deaths by 
the conclusion of the study.  
 Late morbidity outcomes including thromboembolism and reoperation rates were 
also analyzed between patients receiving AVR and AVS. Of the 370 patients who 
survived 30 days beyond their operation, 19 patients suffered from thromboembolism. 
All 19 patients belonged to the AVR group. Forty-nine patients (13.2%) of the 370 
original survivors underwent late aortic surgeries (classified as the aortic arch and 
distal to this) for worsening aneurysm or dissection of the residual aorta. In total, 
freedom from reoperation at five, 10, 15, and 20 years was 95.6%, 88.8%, 82.2%, and 
72.1%, respectively. The researchers also found that having a pre-existing aortic 
dissection prior to the operation played a major role in long-term survival rate and 
freedom from reoperation among MFS patients. For patients who presented initially 
with aortic dissection, freedom from reoperation at 10 years was 67%, and at 20 years 
43%. For those patients without initial dissection, freedom from reoperation at 10 years 
was 92%, and at 20 years was 77%.  
 The researchers utilized several variables to determine risk factors that might 
contribute to early and late morbidity and mortality, and analyzed the variables using 
univariate and multivariate statistical models. These risk factors included patient age, 
concomitant mitral valve surgery, preoperative aortic dissection, NYHA class III/IV 
heart failure status, urgent surgery, and male gender.  Independent mortality predictors 
as shown using univariate analysis were the presence of preoperative aortic dissection 
(Hazard Ratio 2.33, p=0.002), poor NYHA heart failure status of grade III/IV (Hazard 
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Ratio 2.24, p=0.001), and need for emergent surgery (Hazard Ratio 2.51, p=0.003). 
However, using multivariate analyses the authors showed that only concomitant mitral 
valve surgery (Hazard Ratio 1.85, p=0.039) and preoperative aortic dissection (Hazard 
Ratio 1.90, p=0.054) were predictors of early and late mortality that were statistically 
significant.   
 Cameron et al. (2009) concluded that patients with the Marfan syndrome benefit 
from prophylactic surgical intervention and replacement of the aortic root to prevent 
late complications from aneurysm and dissection, be it by AVR or AVS. The study 
demonstrated that there is a lower risk of thromboembolism in valve-sparing 
procedures. The initial desire to avoid life-long anticoagulation was also satisfied. Still, 
because of lack of long-term follow-up in the AVS group, the authors determined it is 
yet unknown how durable AVS is compared to traditional AVR regarding late mortality 
and freedom from reoperation. The authors concluded that not all Marfan patients are 
candidates for AVS, which largely depends on whether or not their aortic leaflets are 
healthy enough to support AVS in the long-term. This is largely based on physician 
opinion and preference at the time of surgery.  
Comparison of Aortic Valve-sparing Reimplantation Versus Composite Grafting 
 Karck et al. (2004) conducted a retrospective cohort study involving 132 patients 
previously diagnosed with Marfan syndrome who underwent aortic root surgeries at 
Hannover Medical School in Hannover, Germany between March 1979 and April 2002. 
Seventy-four patients with MFS underwent AVR, and 45 patients received AVS. 
Together, these two cohorts consisted of a total of 119 patients. The remaining 13 
patients who underwent aortic root replacement during the study period received 
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certain procedures not related to either AVR with mechanical aortic valve or AVS, and 
were therefore not included in final analysis. Follow-up was conducted on an annual 
basis. The mean follow-up in patients who had AVR was 114 ± 63 months (range 2-
249), compared to 30 ± 27 months (range 1-95) for AVS patients. The authors indicate 
that no patients were lost to follow-up. As part of follow-up, serial echocardiography 
was completed in patients who underwent AVS, and patients who had aortic dissection 
and sub-critical dilatation of the aorta underwent routine computed tomography as a 
method to monitor for late complications.  
Patient characteristics 
 At study conclusion, a total of 74 patients underwent AVR. The mean age in the 
AVR group was 35 ± 11 years. Forty-five patients underwent AVS with a mean age of 
28 ± 12 years. A total of 29 (64%) males and 16 (36%) females received AVS. Forty-
nine males (66%) and 25 (34%) females underwent AVR. In the AVS cohort, three 
(7%) patients had acute aortic dissections, and one (2%) had a chronic dissection. 
Among the AVR group, 17 (23%) patients had acute dissections, and 22 (30%) had 
chronic dissections. Nine (12%) patients in the AVR cohort were noted to have had 
previous cardiac surgery, compared to zero in the AVS group.  
Operative techniques 
 Of the 45 patients who received AVS, each underwent a David reimplantation 
operation. Extracorporeal circulation time was longer in the AVS group: 162 ± 34 
minutes, compared to 124 ± 45 minutes in the AVR group with a statistically significant 
p value (p=0.0001). There were additional procedures completed in the AVS patients 
that were statistically significant. Eight (18%) AVS patients had concomitant mitral 
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valve repair, compared to zero in the AVR group (p= <0.0001). Ninety-nine patients 
underwent elective operations, compared to 20 patients who underwent emergent 
surgeries for acute aortic dissection.  
Early results 
 Early mortality results showed five (6.8%) patients in the AVR group died before 
hospital discharge. Of these five patients, three patients died from complications 
associated with mediastinal bleeding, one patient died from sepsis, and one died from 
stroke. There were no early mortalities in the AVS group. Eight patients in the AVR 
group and two patients in the AVS group needed early reoperation to determine a 
source of mediastinal hemorrhage. The length of hospital stay was slightly longer in the 
AVR group 20 ± 18 days, and 15 ± 9 days in the AVS group. The researchers reported 
no perioperative incidence of cerebrovascular accident, myocardial infarction, or 
infection in the AVS cohort. Two patients in the AVR group had non-mortal strokes, two 
patients sustained neurological deficits secondary to cerebral ischemia, and one 
patient had a transient ischemic attack. In the early follow-up period, 12 patients in the 
AVR group sustained hemorrhages unrelated to surgery. Three patients developed 
cerebral hemorrhage, three had retinal bleeding, three had gastrointestinal bleeding, 
and three more developed severe epistaxis. There was no hemorrhage reported in the 
AVS cohort during early follow-up.  
Late results 
 Late survival rates were measured at one year, five years, and 10 years in the 
AVR group and compared to survival rates in the AVS group. At one year in the AVR 
cohort, survival was 97 ± 2%, at 5 years 89 ± 4%, and at 10 years 76 ± 4%. Duration of 
 16 
survival for the AVS cohort measured 100% at one year, and 96 ± 4% at five years, 
though the comparison was not statistically significant (p=0.54). There were no data in 
the AVS group regarding survival that extended to 10 years or beyond. Rates of 
reoperation were also measured during late follow-up in both cohorts. Aortic valve 
reoperation in the AVS group occurred in four patients (9%) due to complications with 
aortic valve incompetence, aortic insufficiency, and subsequent distal aortic 
replacement. All four patients ultimately received AVR with mechanical valve 
prosthesis following reoperation. A total of seven patients (9%) in the AVR cohort 
underwent subsequent reoperation. Six of these patients required reoperations on the 
composite graft placed at the initial operation. One patient received a heart transplant 
after worsening cardiomyopathy following AVR. Two of the seven patients died during 
the early postoperative period. Freedom from reoperation was calculated in both 
groups and again measured at one, five, and 10 years following initial operation. In the 
AVR cohort, freedom from reoperation was 97 ± 2% at 1 year, 92 ± 3% at 5 years, and 
92 ± 3% at 10 years. In the AVS group, freedom from reoperation was 95± 4% at one 
year, and 84 ±8% at five years. There was no statistical significance between the 
differences (p=0.31).  
 Karck et al. (2009) concluded that in-hospital mortality, survival rate at five 
years, and incidence of reoperation between AVR and AVS patients with MFS were 
similar. The authors determined that despite the fact that long-term follow-up is needed 
to elucidate differences in overall mortality, AVS root replacement surgeries appear to 
be effective in the short-term, and prevent patients from having to sustain lifelong 
anticoagulation regimens.  
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Aortic Valve Operative Outcomes in Marfan Patients 
 Volguina et al. (2009) analyzed perioperative and early 30-day outcomes in 151 
MFS patients who underwent either AVR or AVS in this prospective cohort study. 
Eighteen centers in Europe, and North and South America consecutively enrolled 
patients who met criteria for Marfan syndrome between March 2005 and January 2008. 
Criteria for enrollment included patient consent, need for aortic root surgery, availability 
for prospective follow-up, and previous diagnosis of Marfan syndrome. Participating 
study sites gathered patient data and preoperative status, type and method of 
operation, and post-operative status that was submitted to a central Data Coordination 
Center (DCC) for pooled analysis. To ensure quality control, the DCC performed 
annual inspections of participating facilities and verified protocol compliance, and 
appropriate documentation. The primary outcome the authors were looking for was 
incidence of any and all valve-related complications within 30 days of surgery. The 
researchers set a target sample size of 250 patients that would provide 80% power (α 
= 0.05) to distinguish a 1.85-fold increase in relative risk of valve-related problems 
between both AVR and AVS cohorts. This statistical measure was determined by an 
estimated event rate of approximately 20%.  
Patient characteristics 
 Baseline patient variables including aortic dimensions, preexisting acute and 
chronic dissections, ejection fraction, and prevalence of diabetes, hyperlipidemia, 
hypertension, coronary artery disease, mitral valve disease and coagulopathies were 
similar between groups. Still, patient characteristics differed in a number of significant 
ways. Patient age in the AVR group was 39 ± 13 years, compared to 31 ± 12 years (p 
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<0.01) in the AVS group. Significantly more patients in the AVR group had severe 
(9/45, 20%) aortic regurgitation compared to AVS where prevalence of severe aortic 
regurgitation was (5/99, 5%). Also, a disproportionate number of patients in the AVR 
group had previously undergone cardiovascular surgery (6, 13%) compared to four 
patients (4%) in AVS cohort.  
Operative techniques & data 
 Urgent and emergent surgeries were more likely in the AVR group (n=12, 24%) 
than 6 (6%) in the AVS group. Perfusion techniques were similar between both groups. 
Median cardiopulmonary bypass time differed between groups with median time for 
AVR 148 minutes (range 107-199) and 191 minutes (range 157-271) for AVS (p 
<0.01). Median aortic cross-clamp times were also different. In the AVR group, median 
cross clamp time was 114 minutes (range 76-166) and 150 (120-225) in the AVS group 
(p <0.01).  The researchers determined from questionnaire data completed by the 
participating surgeons that final decisions to perform AVR or AVS were made 
intraoperatively almost half of the time (43%).  
Early morbidity and mortality 
 Early results showed there were no 30-day, intraoperative, or in-hospital 
mortalities in either the AVR or AVS group. Valve-related problems occurred in both 
groups during the 30-day postoperative period and were similar 2/46 (4%) in the AVR 
group, versus 3/105 (3%) in the AVS group. The authors showed that this was not 
statistically significant (p=0.6). Complications including embolism, acute renal failure, 
mediastinal bleeding, and multiple organ failure were similar between groups. Cardiac 
complications such as arrythmia, pericardial effusions and cardiac failure were also 
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similar. Although total time spent recovering in the ICU was greater in the AVR group, it 
was not statistically significant (p=0.5).  
 Volguina et al. (2009) concluded that root replacement in MFS patients with 
AVR or AVS had low mortality rates at least in the short-term post-operative period. 
Also, they demonstrated through statistical analysis that the type of root replacement 
received (AVR vs AVS) was not a predictor of early valve-related complications. The 
researchers concluded aortic root replacement with AVS was the most common 
procedure performed in clinical practice.  
DISCUSSION 
GRADE 
 According to the aforementioned GRADE system, the quality of the evidence is 
defined in the following manner: 
High quality— Further research is very unlikely to change our confidence in the 
estimate of effect. 
Moderate quality— Further research is likely to have an important impact on our 
confidence in the estimate of effect and may change the estimate. 
Low quality— Further research is very likely to have an important impact on our 
confidence in the estimate of effect and is likely to change the estimate. 
Very low quality— Any estimate of effect is very uncertain. (Guyatt et al., 2008, 
p. 926) 
 
Since all three studies included in this systematic review were cohort studies, by virtue 
of their design (according to GRADE) they were categorized as low-quality evidence. 
Unfortunately, each study was unable to increase their grade due to the specific 
limitations that are discussed in detail below. Therefore, the overall GRADE of the 
evidence is deemed low quality (Appendix A, Table 1).  
Study limitations 
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 There are multiple reasons why surgical interventions are difficult to compare 
head-to-head in order to determine superiority by utilizing a randomized control 
methodology. For instance, urgency of surgery, anatomical differences between 
patients, certain ethical considerations, and variations in surgical training and operative 
technique are but a few variables that prevent randomization. Despite this, even small, 
non-randomized studies can be elucidating to some degree and if used in the 
appropriate context can even mold clinical decisions regarding patient care. In this 
systematic review, all three studies included were non-randomized cohort studies and 
are therefore designated low quality due to their design. As such, one of the most 
significant limitations of these studies was that the decision to perform either aortic root 
replacement with AVR or AVS was made intraoperatively by the operating surgeon at 
least half the time, suggesting that bias could have been systematically introduced. 
Additionally, In both Cameron et al. (2009) and Karck et al. (2004), the long duration of 
these retrospective cohort studies of 30 and 23 years, respectively, meant that 
operative techniques were constantly evolving and then being introduced to the study 
populations in an ad-hoc, non-standardized way. Therefore, follow-up times were 
different between groups and subgroups and potentially make the final results less 
significant. It is important to mention that, as valve-sparing reimplantation techniques 
changed during the study’s timeframes, these techniques inevitably replaced older 
methods, thus altering the composition of the AVS study groups and their follow-up 
times to an even greater degree. Yet another potential limitation is the fact that patient 
characteristics between the AVR and AVS cohorts in each study were different in 
several major regards, thus potentially marring statistical significance of outcomes 
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between groups. This fact, and the fairly small study populations potentially made the 
studies more limited in significance.  
Early mortality & morbidity in AVR and AVS 
 All three studies showed similar rates of intraoperative mortality between 
patients who underwent AVR and AVS. In Cameron et al. (2009), there were no 
intraoperative mortalities in patients undergoing elective surgery, and only two deaths 
in patients who underwent emergent surgeries, both of whom ultimately received AVR 
procedures. Karck et al. (2004) showed that five patients who received AVR died in the 
hospital compared to none in the AVS cohort. Volguina et al. (2009) had no 
intraoperative mortalities in either group. It is interesting that despite longer cross-
clamp times and the increased technical demands of AVS surgery, it demonstrated a 
low risk of intraoperative mortality in all three studies. In other words, it would appear 
that all three studies showed that although there is a risk of intraoperative mortality 
associated with AVR and AVS procedures, in younger, healthier MFS patients 
undergoing elective root replacement surgeries, the risk appears to be negligible. Still, 
this fact may become less significant after considering the patients who died 
intraoperatively were older, had greater need for urgent/emergent surgeries, and 
tended to have more acute and chronic aortic dissections than their counterparts who 
underwent elective aortic root replacement with AVS.  
 One study showed there was a higher incidence of early reoperation in the AVR 
group secondary to surgical bleeding complications when compared to the AVS group, 
although this was not highlighted in the other studies (Karck et al., 2004). Volguina et 
al. (2009) demonstrated similar early morbidity outcomes across the board when 
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comparing AVR to AVS. Cameron et al. (2009) did not specifically address early 
morbidity and focused instead, on early mortality.  
Late morbidity in AVR and AVS 
 Only two studies (Cameron et al., 2009, & Karck et al., 2004) had long enough 
follow-up periods to allow them to adequately address late morbidity between the AVR 
and AVS groups. Comparatively, both studies showed similar rates of reoperation 
between AVR and AVS cohorts, though Karck et al. (2004) demonstrated that at the 5-
year follow-up period freedom from reoperation in the AVS group was lower (84% ± 
8%) compared to the AVR group (92% ± 3%). However, the results do not appear to be 
statistically significant with a p-value shown by the authors to be (p=0.31). Specifically, 
the reoperations in the AVS group in the Karck et al. (2004) study were attributed to 
early valve failure secondary to “inadequate technique at the primary repair,” and the 
patients ultimately required mechanical valve prostheses with subsequent lifelong 
anticoagulation with warfarin.  On the other hand, the majority of patients in the AVR 
group in the Karck et al. (2004) study who underwent reoperation, did so due to 
complications of their composite aortic grafts.  
 Although thromboembolic events in the Cameron et al. (2009) study numbered 
fairly low within the AVR group, it was the most ubiquitous complication when looking 
at late morbidity among this group. A total of 19 patients suffered from thromboembolic 
events in the AVR cohort, though freedom from this risk at 20 years was quite good at 
91.5%. Similarly, Karck et al. (2004) discovered that a total of 17 patients in the AVR 
group suffered either bleeding episodes or thromboembolic events during late follow-
up. Neither study specifically addressed whether patients suffering from 
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thromboembolic events or late bleeding complications in the AVR groups did so 
secondary to problematic anticoagulant use such as subtherapeutic INR, non-
compliance with medications, or bleeding attributed to other causes. In fact, how 
patients were medically managed regarding the use of anticoagulants after their 
surgeries was never touched upon in any of the studies.  
Late mortality in AVR and AVS 
 The Cameron et al. (2009) and Karck et al. (2004) studies addressed late 
mortality, though follow-up times were much longer in the AVR group compared to 
those in the AVS group. Cameron et al. (2009) noted 74 total deaths in those who 
survived to discharge. Seventy of those patients had aortic root replacement with AVR. 
The most common causes of death in this group were attributed to residual aortic 
dissection or rupture, and cardiac arrhythmia. Two late deaths were attributed to aortic 
root replacement with AVS. Interestingly, of the total 85 patients who underwent AVS, 
the two deaths were in the subgroup that received the earlier “remodeling” AVS 
technique. There were no deaths in the “reimplantation” subgroup by the study’s 
conclusion. However, because the exact amount of follow-up time was not specifically 
indicated between the groups and subgroups in the Cameron et al. (2009) study, it is 
difficult to find statistical significance in the data. Late mortality and survival rates were 
also similar in the Karck et al. (2009) study. Although this study, too, had varied 
amounts of follow-up time between AVR and AVS groups, at five years survival was 
96% ± 4% for AVR, and 89% ± 4%, though this was not shown to be statistically 
significant (p=0.54). Indeed, at 15 years posteroperatively, survival rates in the AVR 
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group approximated survival rates in the AVS group measured at five years. Longer 
follow-up in the AVS group will be needed to elucidate further differences in outcome.  
CONCLUSION 
Prophylactic aortic root replacement should be offered as an elective surgery to 
MFS patients with dilated aortic roots who may be at risk for catastrophic aortic 
dissection or aortic rupture. Although aortic root replacement with either AVR or AVS 
appears to provide a low risk of intraoperative and early mortality, there are insufficient 
long-term data that support recommending valve-sparing (AVS) procedures over valve-
replacing (AVR) procedures. Because aortic root replacement with AVR is the “gold 
standard” with proven durability despite the concomitant need for life-long 
anticoagulation, it should continue to be the standard of care for aortic root 
replacement in MFS patients. More long-term follow-up regarding late mortality in MFS 
patients who have received aortic root replacement with AVS is needed before there is 
a paradigm shift. 
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List of Abbreviations 
 
AVR – aortic valve-replacing (a.k.a. aortic valve-replacing root replacement) 
 
AVS – aortic valve-sparing (a.k.a. aortic valve-sparing root replacement) 
 
MFS – Marfan syndrome 
 
DCC – Data Coordination Center 
 
INR – International normalized ratio 
 
 
 
